Skip to content

Angelman Syndrome Due To Imprinting Defect In 15q11 Q13 C5681834

Published: July 22, 2026Updated: August 27, 2026

A genetic neurodevelopmental disorder due to an imprinting defect in chromosome 15q11-q13. Children show severe developmental delay, characteristic facial features, and movement problems. Treatment involves supportive care, physical therapy, and seizure management.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizures

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Severe intellectual disability

(neurologic)

Microcephaly

(neurologic)

Hypopigmentation of skin

(integumentary)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Anticonvulsant therapy

Seizure management using anticonvulsant medications is essential for individuals with Angelman syndrome due to imprinting defects. The choice of anticonvulsant should be tailored to seizure type and patient response, with regular monitoring for efficacy and side effects.

medication
2

Targeted drug therapy with dose adjustment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Physical and occupational therapy

Early intervention physical and occupational therapy programs help improve motor coordination, balance, and functional abilities in children with Angelman syndrome. Therapy focuses on movement patterns, strength building, and adaptive techniques for daily activities.

physical_therapy

Additional treatment options

Communication and speech therapy

Speech-language therapy utilizing augmentative and alternative communication systems significantly improves communication outcomes. Therapists work on developing gesture-based communication, picture exchange systems, and adaptive communication devices.

psychological

Sleep hygiene and management

Establishing consistent bedtime routines and environmental modifications helps address sleep disturbances common in Angelman syndrome. Sleep management may include structured schedules, environmental controls, and behavioral strategies.

lifestyle

Multidisciplinary developmental monitoring

Regular assessments by a team of specialists including neurologists, geneticists, and developmental pediatricians ensure comprehensive care. Monitoring tracks developmental progress, identifies emerging needs, and adjusts intervention strategies.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Angelman Syndrome Due To Imprinting Defect In 15q11 Q13 C5681834?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Williams CA, Beaudet AL, Clayton-Smith J, et al. Angelman syndrome 2005: updated consensus for diagnostic criteria. Am J Med Genet A. 2006.

guideline2006
2

Lossie AC, Whitney MM, Amidon D, et al. Distinct phenotypes distinguish the molecular classes of Angelman syndrome. J Med Genet. 2001.

review2001
3

Gentile JK, Goto MP, Zahorak C, et al. A prospective study of sleep in individuals with Angelman syndrome. Neuropsychiatr Dis Treat. 2018.

clinical_trial2018
4

Dagli AI, Mueller J, Williams CA. Angelman syndrome: a review of clinical and genetic aspects. Am J Med Genet C Semin Med Genet. 2009.

meta_analysis2009

Medication Comparisons

Compare medications used to treat Angelman Syndrome Due To Imprinting Defect In 15q11 Q13 C5681834. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy